To assess longer-term patterns of glaucoma medication adherence and identify whether patterns established during the first year of medication use persist during 3 subsequent years of follow-up.

To evaluate the long-term effectiveness and safety of mitomycin C (MMC)–augmented trabeculectomy undertaken within the first 2 years of life for the surgical management of glaucoma.

To evaluate the vascular structure of eyes with macular telangiectasia type 2 (MacTel2) using volume-rendered optical coherence tomography angiography (OCTA).

To determine whether screening for age-related macular degeneration (AMD) during a diabetic retinopathy (DR) screening program would be cost effective in Hong Kong.

Multiple sclerosis (MS) is an inflammatory demyelinating disorder of the central nervous system characterized by progressive neurodegeneration. Current management aims to reduce the inflammation through immunomodulation. However, the effectiveness of these treatments for preventing degeneration is unclear. Vascular alterations, which may be caused by inflammatory cerebral endotheliopathy,1 could play a role in neurodegeneration. Indeed, increased incidence of ischemic stroke and diffuse hypoperfusion in normal-appearing white and gray matter have been reported in MS patients.

The in vivo microstructural features of familial exudative vitreoretinopathy (FEVR) have not been well described. We present new anatomic features of FEVR with functional and genetic correlations.